Although considered as a reliable mobilizing agent, continuous AMD application seems to attenuate positive effects of stem cell mobilization due to blockade of SDF-1α/CXCR4 mediated stem cell homing [13], [14]. This evidence concerns the gene CXCL12 and age-related macular degeneration.